ORAGENICS INC (OGEN)

↓ Download CSV

CIK 0001174940 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated FL
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-118.9%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$37.7K$131.5K$87.0K
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$9.36M-$10.56M-$20.90M-$14.42M-$15.77M-$26.64M-$15.88M-$9.99M-$6.72M-$8.54M
Net Income-$9.84M-$10.57M-$20.66M-$14.29M-$15.71M-$26.43M-$15.57M-$9.91M-$6.73M-$7.01M
EPS (Diluted)$-4.56$-47.88$-9.18$-7.11$-8.09$-0.47
Total Assets$10.07M$1.47M$4.97M$14.76M$28.23M$18.68M$19.75M$22.05M$7.21M$4.31M
Total Liabilities$1.79M$1.68M$1.80M
Shareholders' Equity$8.28M-$211.9K$3.17M$13.01M$26.49M$16.84M$17.23M$20.88M$6.32M$2.97M
Cash & Equivalents$4.40M$864.8K$3.48M$11.43M$27.27M$17.64M$18.27M$20.21M$6.17M$4.08M
Operating Cash Flow-$9.25M-$8.60M-$7.29M-$15.23M-$13.47M-$16.95M-$13.01M-$9.08M-$6.36M-$7.08M
Capital Expenditures$127.5K$43.9K$25.2K$124.7K$27.2K
Shares Outstanding4.27M419.0K3.08M2.02M2.00M91.77M46.12M29.43M4.93M4.91M